Centene Corporation · NYSE:CNC
Centene — Morgan Stanley Global Healthcare Conference 2021
9 slides from Centene's conference presentation, September 2021
Slide 1: Morgan Stanley Global Healthcare Conference 2021
Morgan Stanley Michael F. Neidorff Chairman & Sarah London Vice Chairman Global Healthcare Chief Executive Officer Conference 2021 Brent Layton President & Chief Drew Asher EVP & Chief Financial Operating Officer Officer
Slide 2: Forward-Looking Statements
Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this presentation are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "in
Slide 3: Centene – Enhanced Organizational Leadership
Centene – Enhanced Organizational Leadership SARAH LONDON BRENT LAYTON DREW ASHER Vice Chairman, Board President & Chief EVP & Chief Financial of Directors Operating Officer Officer Key appointments further align Centene’s organizational structure and operating model with its strategic priorities, a
Slide 4: Centene – Leader in Government-Sponsored Healthcare
Centene – Leader in Government-Sponsored Healthcare Largest Medicaid Managed Care Strong Growth in 2021 Revenue Strong Organization Medicare Advantage over $123B Foundation to Unlock Value and Drive Margin #1 Marketplace Providing health coverage to 25 Expansion Carrier million members 4
Slide 5: Select Business Updates – Ongoing Progress
Select Business Updates – Ongoing Progress North Carolina launch; Ohio update Continued Medicare Growth Supportive Administration for Government Sponsored Products Magellan on track Commitment to Value Creation Plan 5
Slide 6: Update on 2021 and Earnings Outlook
Update on 2021 and Earnings Outlook July/August Observations • Observed subsidence in non-COVID utilization in July • COVID inpatient authorizations pick up in late July due to Delta variant, ramp up for first 3 weeks of August and begin to settle in late August • Non-COVID utilization serves as an
Slide 7: Execution of Value Creation Plan to Deliver EPS Growth
Execution of Value Creation Plan to Deliver EPS Growth Strong EPS New PBM Contract Growth from RFP Operating Model Platform Standardization Consolidation Procurement Real Estate Advancement Monetization Targeted Refinancing SG&A Improved Initiatives Bid Process JUMP-OFF 2024 Clinical Share 2021 Init
Slide 8: Initiatives to Deliver 3.3% Adjusted Net Income Margin and Value Creation Underway
Initiatives to Deliver 3.3% Adjusted Net Income Margin and Value Creation Underway Nearer Term 2023/2024 Process and Accountability Targeted SG&A Initiatives • London, Layton and Asher Refinancing driving Value Creation Plan Clinical Initiatives • Execution work streams established to support Value
Slide 9: Disciplined Capital Deployment
Disciplined Capital Deployment 1/3 Organic Growth Risk based capital and investments in products and technology to Strong drive future growth long-term cash flow Capital Management and M&A supports Value creation focus and capital allocation levers to deliver value capital 2/3 Debt management M&A Sh
Centene — Morgan Stanley Global Healthcare Conference 2021 on 6ix